Atrás
Rango del Día
$16.50
$17.32
Rango de 52 Semanas
$5.95
$62.75
Volumen
774,940
Promedio 50D / 200D
$16.85
/
$29.02
Cierre Anterior
$16.27
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -5.3 | 0.4 |
| P/B | 4.0 | 2.9 |
| ROE % | -60.5 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.3 | 0.2 |
Precio Objetivo de Analistas
Hold
$19.88
+17.8%
Low: $8.00
High: $35.00
EPS Futuro
-$3.65
Ingresos Est.
0
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$2.74
$1.74 – $4.15
|
900 M | 6 |
| FY2029 |
-$0.48
-$0.72 – -$0.30
|
450 M | 6 |
| FY2028 |
-$2.59
-$4.77 – -$0.86
|
140 M | 8 |
Puntos Clave
Debt/Equity of 0.25 — conservative balance sheet
Negative free cash flow of -196.04M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-60.51%
ROIC-48.30%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.25
Current Ratio9.27
Interest Coverage-33.78
Valoración
P/E Ratio
-5.32
P/B Ratio3.97
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -227.32M |
| ROE | -60.51% | ROA | -53.56% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -196.04M |
| ROIC | -48.30% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.25 | Current Ratio | 9.27 |
| Interest Coverage | -33.78 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -5.32 | P/B Ratio | 3.97 |
| P/S Ratio | N/A | PEG Ratio | -0.04 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.21B | Enterprise Value | 951.24M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -227.32M | -118.94M | -36.01M | -49.97M | -53.64M |
| EPS (Diluted) | -3.53 | -1.89 | -0.73 | -2.20 | -1.45 |
| Gross Profit | -2.62M | 0.0 | 0.0 | 0.0 | -4,971.0 |
| Operating Income | -244.83M | -143.09M | -54.12M | -65.06M | -53.58M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 424.43M | 477.93M | 526.54M | 76.84M | 9.68M |
| Total Liabilities | 119.95M | 24.54M | 13.05M | 8.08M | 21.33M |
| Shareholders' Equity | 304.48M | 446.83M | 495.68M | 48.90M | -11.65M |
| Total Debt | 75.71M | 2.83M | 3.70M | 282,580.0 | 15.00M |
| Cash & Equivalents | 334.52M | 180.43M | 451.17M | 39.51M | 8.04M |
| Current Assets | 421.69M | 474.29M | 514.17M | 76.51M | 9.64M |
| Current Liabilities | 45.48M | 22.46M | 9.97M | 7.67M | 21.09M |